CUE
Price
$0.31
Change
+$0.01 (+3.33%)
Updated
Feb 13 closing price
Capitalization
28.11M
38 days until earnings call
Intraday BUY SELL Signals
QNCX
Price
$0.20
Change
-$0.03 (-13.04%)
Updated
Feb 13 closing price
Capitalization
11.13M
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CUE vs QNCX

Header iconCUE vs QNCX Comparison
Open Charts CUE vs QNCXBanner chart's image
Cue Biopharma
Price$0.31
Change+$0.01 (+3.33%)
Volume$352.04K
Capitalization28.11M
Quince Therapeutics
Price$0.20
Change-$0.03 (-13.04%)
Volume$181.5M
Capitalization11.13M
CUE vs QNCX Comparison Chart in %
CUE
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CUE vs. QNCX commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUE is a Hold and QNCX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (CUE: $0.31 vs. QNCX: $0.20)
Brand notoriety: CUE and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CUE: 23% vs. QNCX: 434%
Market capitalization -- CUE: $28.11M vs. QNCX: $11.13M
CUE [@Biotechnology] is valued at $28.11M. QNCX’s [@Biotechnology] market capitalization is $11.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CUE’s FA Score shows that 1 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • CUE’s FA Score: 1 green, 4 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, CUE is a better buy in the long-term than QNCX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CUE’s TA Score shows that 3 TA indicator(s) are bullish while QNCX’s TA Score has 5 bullish TA indicator(s).

  • CUE’s TA Score: 3 bullish, 3 bearish.
  • QNCX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CUE and QNCX are a good buy in the short-term.

Price Growth

CUE (@Biotechnology) experienced а -4.22% price change this week, while QNCX (@Biotechnology) price change was +43.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Reported Earning Dates

CUE is expected to report earnings on Mar 24, 2026.

QNCX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CUE($28.1M) has a higher market cap than QNCX($11.1M). CUE YTD gains are higher at: 0.393 vs. QNCX (-94.030). CUE has higher annual earnings (EBITDA): -35.19M vs. QNCX (-44.18M). QNCX has more cash in the bank: 26.3M vs. CUE (18.7M). CUE has less debt than QNCX: CUE (6.17M) vs QNCX (18M). CUE has higher revenues than QNCX: CUE (7.1M) vs QNCX (0).
CUEQNCXCUE / QNCX
Capitalization28.1M11.1M253%
EBITDA-35.19M-44.18M80%
Gain YTD0.393-94.030-0%
P/E RatioN/AN/A-
Revenue7.1M0-
Total Cash18.7M26.3M71%
Total Debt6.17M18M34%
FUNDAMENTALS RATINGS
CUE vs QNCX: Fundamental Ratings
CUE
QNCX
OUTLOOK RATING
1..100
790
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9399
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
1750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CUE's Valuation (24) in the Biotechnology industry is in the same range as QNCX (51). This means that CUE’s stock grew similarly to QNCX’s over the last 12 months.

CUE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as QNCX (100). This means that CUE’s stock grew similarly to QNCX’s over the last 12 months.

CUE's SMR Rating (100) in the Biotechnology industry is in the same range as QNCX (100). This means that CUE’s stock grew similarly to QNCX’s over the last 12 months.

CUE's Price Growth Rating (93) in the Biotechnology industry is in the same range as QNCX (99). This means that CUE’s stock grew similarly to QNCX’s over the last 12 months.

CUE's P/E Growth Rating (100) in the Biotechnology industry is in the same range as QNCX (100). This means that CUE’s stock grew similarly to QNCX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CUEQNCX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CUE
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSRM28.112.18
+8.41%
SSR Mining
NPKI14.440.49
+3.51%
NPK International Inc
SO94.952.39
+2.58%
Southern Company (The)
RCKY33.110.14
+0.42%
Rocky Brands
ZBAO0.81-0.05
-5.79%
Zhibao Technology

CUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CUE has been closely correlated with ARTV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CUE jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUE
1D Price
Change %
CUE100%
+2.20%
ARTV - CUE
73%
Closely correlated
+0.25%
VTGN - CUE
73%
Closely correlated
-7.23%
TPST - CUE
72%
Closely correlated
+2.16%
MREO - CUE
70%
Closely correlated
-4.32%
QNCX - CUE
69%
Closely correlated
-11.31%
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been closely correlated with ARTV. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if QNCX jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
-11.31%
ARTV - QNCX
94%
Closely correlated
+0.25%
CALC - QNCX
85%
Closely correlated
-6.41%
RZLT - QNCX
83%
Closely correlated
+5.79%
GNTA - QNCX
82%
Closely correlated
-1.12%
VTGN - QNCX
79%
Closely correlated
-7.23%
More